arrow
J

John W.M. Martens

erasmus mc cancer institute
H指数:100
被引数:5.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-specific super-enhancer drives overexpression of EVI1/MECOM in ovarian cancer

肿瘤特异性超级增强子驱动卵巢癌中<em>EVI1/MECOM</em>的过表达

2026-10-120
OAAI
Elevated baseline DNA damage and hypomethylated circulating free DNA distinguish frailty from healthy aging

高基线DNA损伤和低甲基化循环游离DNA区分衰弱与正常衰老

2026-09-040
OAAI
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer

循环肿瘤细胞通过活检或FES-PET评估之外增强内分泌治疗转移性乳腺癌的预后分层

2026-04-170
OA
Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases

可切除结直肠癌肝转移患者围手术期循环肿瘤DNA水平的预后价值,该水平由游离DNA甲基化估计

2026-03-280
OAAI
Clinical Trial Protocol for the Apa/Enza-short Study: A Randomized Nationwide Study of Shortened 12-Month Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Metastatic Low-volume Castration-sensitive Prostate Cancer

Apa/Enza-short研究临床试验方案:一项全国性随机研究,评估在联合雄激素剥夺疗法的情况下,对转移性低体积去势敏感前列腺癌患者使用雄激素受体信号抑制剂缩短至12个月的治疗持续时间。

2026-03-120
PRE
Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from methylated DNA sequencing data

通过同时从甲基化DNA测序数据中提取DNA甲基化与拷贝数信息,改进循环肿瘤DNA分析

2025-12-150
OA
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study

循环肿瘤细胞 & 循环肿瘤DNA在可切除结直肠癌肝转移患者中的研究(MIRACLE):一项前瞻性、观察性生物标志物研究

2025-08-120
PREAI
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets

泛癌种蛋白质组图谱,一种基于质谱技术的景观,用于发现肿瘤生物学、生物标志物和 therapeutic targets

2025-05-290
PRE
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2024-08-210
OAAI